Yali Zhang
School of Chemical Engineering
Faculty of Sciences, Engineering and Technology
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Emerging therapies are more likely to rely on the delivery of biological therapeutics to the cytosol. Nanoparticles (NPs) have shown significant potential for delivery and successfully entered clinical use. However, most nanoparticles taken up by endocytosis either accumulate in endosomes and lysosomes or are pumped out through exocytosis, where they are not active for therapeutic functions. Current studies on how to enhance endosomal escape and release are hampered by a lack of quantitative methodology to detect NP delivery efficiency. Dr Zhang is developing quantitative assays to probe endosomal escape and cytosolic delivery of NPs, which provides a better understanding of endocytosis pathways and is beneficial to nanomedicine engineering.
-
Language Competencies
Language Competency Chinese (Mandarin) Can read, write, speak, understand spoken and peer review English Can read, write, speak, understand spoken and peer review -
Education
Date Institution name Country Title Griffith University Australia Bachelor with first class honours University of South Australia Australia PhD -
Postgraduate Training
Date Title Institution Country Postdoc fellowship The University of Adelaide Australia -
Research Interests
-
Journals
2018 Griffith University: Lab demonstrator and assistant
2021 University of South Australia: Lab demonstrator and assistant
2022 The University of Adelaide College/Kaplan: Academic teacher for biology
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2024 Co-Supervisor Development of Cancer-on-a-Chip Platforms for Drug Screening Doctor of Philosophy Doctorate Full Time Mr Max George Higham
Connect With Me
External Profiles
